[{"id":5540,"regimens":[{"id":10334,"duration":{"id":4311,"approximate_duration":"10 days","dates_unknown":true},"drug":{"id":6677,"name":"Cefuroxime","url":"cure-api2.ncats.io/v1/drugs/6677","rxNorm_id":null,"notes":null},"use_drug":[{"id":6251,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10334},{"id":6347,"answer":"In a novel combination with another drug","answer_other":"","regimen":10334}],"created":"2020-05-19T17:57:45.212986Z","updated":"2020-10-05T23:00:11.112974Z","dose":"1.5 g","frequency":"","route":"IV","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5540},{"id":10335,"duration":{"id":4312,"approximate_duration":"10 days","dates_unknown":true},"drug":{"id":10942,"name":"Umifenovir","url":"cure-api2.ncats.io/v1/drugs/10942","rxNorm_id":null,"notes":null},"use_drug":[{"id":6252,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10335},{"id":6348,"answer":"In a novel combination with another drug","answer_other":"","regimen":10335}],"created":"2020-05-19T17:57:45.221064Z","updated":"2020-10-05T23:00:11.148491Z","dose":"200 mg","frequency":"TID","route":"Oral","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5540},{"id":10336,"duration":{"id":4313,"approximate_duration":"10 days","dates_unknown":true},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":6253,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10336},{"id":6349,"answer":"In a novel combination with another drug","answer_other":"","regimen":10336}],"created":"2020-05-19T17:57:45.228058Z","updated":"2020-10-05T23:00:11.126085Z","dose":"200/50 mg","frequency":"BID","route":"Oral","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5540}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7299,"answer":"PCR","answer_other":"","report":5540},{"id":7300,"answer":"Imaging","answer_other":"","report":5540},{"id":7332,"answer":"Clinical assessment","answer_other":"","report":5540}],"how_diagnosis":[{"id":12115,"answer":"PCR","answer_other":"","report":5540},{"id":12116,"answer":"Imaging","answer_other":"","report":5540},{"id":12174,"answer":"Clinical assessment","answer_other":"","report":5540}],"author_username":"Parvesh Paul","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"Christian Medical College, Ludhiana, Punjab, India.","author_country":"India","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3365,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5540}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-05-19T17:55:04.258921Z","updated":"2020-10-05T23:00:11.105091Z","title":"Computed tomography manifestations of COVID-19 pneumonia.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32339019,"doi":"10.12968/hmed.2020.0104","article_url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=32339019","pub_year":2020,"published_authors":"An P\r\nLiu B","article_author_email":"liuxyyy2015@163.com","journal":"British journal of hospital medicine (London, England : 2005)","abstract":"Abstract could not be found.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"41-50 years","sex":"Female","ethnicity":null,"country_contracted":"China","country_treated":"China","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Respiratory tract infection","severity":"ICU/Critical Care","prev_treatment":"","unusual":"","drug_treatment_features":"Patient was given supplemental oxygen, intravenous cefuroxime 1.5 g, oral arbidol tablets (200mg, three times a day), and lopinavir/ritonavir 200/50mg two tablets per day. After 10 days of standard treatment (based on the revised fifth edition of the novel coronavirus pneumonia diagnosis and treatment plan; General Office of the National Health and Health Commission, 2020)","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6677,8783,10942]},{"id":6157,"regimens":[{"id":11702,"duration":{"id":5716,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":8628,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11702},{"id":8629,"answer":"In a novel combination with another drug","answer_other":"","regimen":11702}],"created":"2020-09-30T15:52:15.720775Z","updated":"2020-10-04T23:10:32.579420Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6157},{"id":11703,"duration":{"id":5717,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":8630,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11703},{"id":8631,"answer":"In a novel combination with another drug","answer_other":"","regimen":11703}],"created":"2020-09-30T15:52:15.728462Z","updated":"2020-10-04T23:10:32.585732Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6157},{"id":11704,"duration":{"id":5718,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":6122,"name":"Azithromycin","url":"cure-api2.ncats.io/v1/drugs/6122","rxNorm_id":null,"notes":null},"use_drug":[{"id":8632,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11704},{"id":8633,"answer":"In a novel combination with another drug","answer_other":"","regimen":11704}],"created":"2020-09-30T15:52:15.734810Z","updated":"2020-10-04T23:10:32.591548Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6157},{"id":11705,"duration":{"id":5719,"approximate_duration":"7 days","dates_unknown":true},"drug":{"id":6677,"name":"Cefuroxime","url":"cure-api2.ncats.io/v1/drugs/6677","rxNorm_id":null,"notes":null},"use_drug":[{"id":8634,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11705},{"id":8635,"answer":"In a novel combination with another drug","answer_other":"","regimen":11705}],"created":"2020-09-30T15:52:15.741377Z","updated":"2020-10-04T23:10:32.597270Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6157}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8071,"answer":"Clinical assessment","answer_other":"","report":6157},{"id":8072,"answer":"PCR","answer_other":"","report":6157}],"how_diagnosis":[{"id":13758,"answer":"Clinical assessment","answer_other":"","report":6157},{"id":13759,"answer":"PCR","answer_other":"","report":6157}],"author_username":"Eleanor McCartney","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4163,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6157}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-09-30T15:50:53.273081Z","updated":"2020-10-04T23:10:32.570923Z","title":"Renal infarct in a COVID-19-positive kidney-pancreas transplant recipient.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32483909,"doi":"10.1111/ajt.16089","article_url":"https://pubmed.ncbi.nlm.nih.gov/32483909/","pub_year":2020,"published_authors":"Xu JJ\r\nSamaha D\r\nMondhe S\r\nMassicotte-Azarniouch D\r\nKnoll G\r\nRuzicka M","article_author_email":"Author email could not be found.","journal":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","abstract":"The novel coronavirus disease 2019 (COVID-19) is associated with increased risk of thromboembolic events, but the extent and duration of this hypercoagulable state remain unknown. We describe the first case report of renal allograft infarction in a 46-year-old kidney-pancreas transplant recipient with no prior history of thromboembolism, who presented 26 days after diagnosis of COVID-19. At the time of renal infarct, he was COVID-19 symptom free and repeat test for SARS-CoV-2 was negative. This case report suggests that a hypercoagulable state may persist even after resolution of COVID-19. Further studies are required to determine thromboprophylaxis indications and duration in solid organ transplant recipients with COVID-19.          \r\n        Keywords:      \r\n                  clinical research/practice; infection and infectious agents - viral; kidney transplantation/ nephrology; thrombosis and thromboembolism.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"41-50 years","sex":"Male","ethnicity":null,"country_contracted":"Canada","country_treated":"Canada","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":true,"hypertension":true,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":true,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"simultaneous kidney-pancreas transplant 13 years prior","pregnant":false,"unknown":false,"site_of_disease":"lungs, kidney","clinical_syndrome":"pneumonia, segmental renal infarction","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"The patient has a history of dyslipidemia and simultaneous kidney-pancreas transplant 13 years ago from Type 1 diabetes complicated by diabetic nephropathy and neurogenic bladder. Maintenance immunosuppression consisted of tacrolimus, mycophenolate mofetil, and prednisone. Tacrolimus was held due to lopinavir/ritonavir administration. They received a high dose of thromboembolism prophylaxis with enoxaparin 40 mg subcutaneously every 12 hours. On hospital day 8, the patient presented with sharp lower left quadrant pain and a segmental renal infarction. Radiological findings were suggestive of a large-vessel arterial thromboembolism. Patient began anticoagulation with enoxaparin 80 mg subcutaneously every 12 hours was initiated with a plan to switch to apixaban 5 mg p.o. twice daily at discharge for at least 3 months.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6122,6677,8342,8783]}]